[co-CEO of SolGent, You Jae-hyung on the left]

SolGent, an affiliate of EDGC has signed a letter of intent (LOI) with several U.S. states, including New York, California and Nevada in total of 1 million people worth of diagnostic reagents.

“As COVID-19 is widely spreading across several states in U.S., we will use our global network to supply large amount of diagnostic reagents to necessary countries including U.S. to end the pandemic in early stage.”, EDGC Healthcare quoted.

You Jae-hyung, CEO of SolGent has delivered opinions during the meeting with representatives of five detection kit makers and President Moon Jae-in regarding the global crisis.

President Moon personally thanked all of the representatives for their R&D efforts, saying he was “grateful and proud” of them. He listened to the diagnosis reagent production process and was briefed about the current status of emergency use authorization of Korea Centers for Disease Control and Prevention(KCDC)

Mr. You proposed ▲simplifying procedures for reporting changes due to the expansion of GMP (Good Drug Manufacturing and Quality Management) plants, ▲supporting facility equipment, ▲supporting on obtaining U.S. FDA approval and from other countries, ▲ and providing governmental support to enhance global competitiveness through national branding such as K-BIO.